↓ Skip to main content

Cochrane Database of Systematic Reviews

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Overview of attention for article published in this source, April 2013
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
9 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
107 Mendeley
citeulike
1 CiteULike
Title
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
Published by
John Wiley & Sons, Ltd, April 2013
DOI 10.1002/14651858.cd009008.pub2
Pubmed ID
Authors

Hemmingsen, Bianca, Schroll, Jeppe B, Lund, Søren S, Wetterslev, Jørn, Gluud, Christian, Vaag, Allan, Sonne, David Peick, Lundstrøm, Lars H, Almdal, Thomas P

Abstract

Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Denmark 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Unknown 103 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 15%
Student > Master 15 14%
Student > Postgraduate 13 12%
Student > Ph. D. Student 11 10%
Student > Bachelor 9 8%
Other 24 22%
Unknown 19 18%
Readers by discipline Count As %
Medicine and Dentistry 60 56%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Economics, Econometrics and Finance 3 3%
Social Sciences 3 3%
Agricultural and Biological Sciences 2 2%
Other 7 7%
Unknown 26 24%